Skip to main content

Start ENTRESTO® with confidence

ENTRESTO film-coated tablets are available in 3 dosage strengths1 
dosing_desktop.png

How to prescribe ENTRESTO to your adult patients

Choose initial dose of ENTRESTO based on current treatment and titrate to the target dose1

  • ENTRESTO is contraindicated with concomitant use of an ACEi and in patients with a history of angioedema related to previous ACEi or ARB therapy1

  • Avoid use of ENTRESTO with an ARB, because ENTRESTO contains the angiotensin II receptor blocker valsartan1

Unless your patient is on a high ACEi/ARB dose, start ENTRESTO at 24/26 mg twice daily and double the dose every 2 to 4 weeks, as tolerated by the patient. When switching from an ACEi, be sure to allow for a 36-hour washout period prior to initiating ENTRESTO.1

ENTRESTO SPRINKLE film-coated oral pellets are available in 2 dosage strengths1
Sprinkle Dosing

All doses should be taken 2x per day with food. If you have questions regarding your children's dosing needs, please contact your child's doctor or a member of their care team.

Discover support and resources to help your patients start on Entresto

See the clinical trial legacy of ENTRESTO

Learn about the dual mechanism of action of ENTRESTO

*In PARAGON-HF, defined as LVEF ≥45% with structural heart disease (LAE or LVH); median LVEF was 57%. LVEF is a variable measure and the normal range can vary.1

Definitions
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin ‖ receptor blocker; LAE, left atrial enlargement; LVH, left ventricular hypertrophy.

References
1. ENTRESTO [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp.
2. Senni M, McMurray JJV, Wachter R, et al. Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens. Eur J Heart Fail. 2016;18(9):1193-1202. doi:10.1002/ejhf.548